These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31559105)

  • 1. Overview of studies of the vitamin D/vitamin D receptor system in the development of non-alcoholic fatty liver disease.
    Cimini FA; Barchetta I; Carotti S; Morini S; Cavallo MG
    World J Gastrointest Pathophysiol; 2019 Sep; 10(2):11-16. PubMed ID: 31559105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease.
    Cimini FA; Barchetta I; Carotti S; Bertoccini L; Baroni MG; Vespasiani-Gentilucci U; Cavallo MG; Morini S
    World J Gastroenterol; 2017 May; 23(19):3407-3417. PubMed ID: 28596677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte vitamin D receptor regulates lipid metabolism and mediates experimental diet-induced steatosis.
    Bozic M; Guzmán C; Benet M; Sánchez-Campos S; García-Monzón C; Gari E; Gatius S; Valdivielso JM; Jover R
    J Hepatol; 2016 Oct; 65(4):748-757. PubMed ID: 27245430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between hepatic and systemic angiopoietin-like 3, hepatic Vitamin D receptor expression and NAFLD in obesity.
    Barchetta I; Cimini FA; Chiappetta C; Bertoccini L; Ceccarelli V; Capoccia D; Gaggini M; Di Cristofano C; Della Rocca C; Silecchia G; Leonetti F; Lenzi A; Gastaldelli A; Cavallo MG
    Liver Int; 2020 Sep; 40(9):2139-2147. PubMed ID: 32510837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D counteracts fibrogenic TGF-β signalling in human hepatic stellate cells both receptor-dependently and independently.
    Beilfuss A; Sowa JP; Sydor S; Beste M; Bechmann LP; Schlattjan M; Syn WK; Wedemeyer I; Mathé Z; Jochum C; Gerken G; Gieseler RK; Canbay A
    Gut; 2015 May; 64(5):791-9. PubMed ID: 25134788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
    Barchetta I; Del Ben M; Angelico F; Di Martino M; Fraioli A; La Torre G; Saulle R; Perri L; Morini S; Tiberti C; Bertoccini L; Cimini FA; Panimolle F; Catalano C; Baroni MG; Cavallo MG
    BMC Med; 2016 Jun; 14():92. PubMed ID: 27353492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active vitamin D impedes the progression of non-alcoholic fatty liver disease by inhibiting cell senescence in a rat model.
    Ma M; Long Q; Chen F; Zhang T; Wang W
    Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):513-523. PubMed ID: 31810868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D Signaling through Induction of Paneth Cell Defensins Maintains Gut Microbiota and Improves Metabolic Disorders and Hepatic Steatosis in Animal Models.
    Su D; Nie Y; Zhu A; Chen Z; Wu P; Zhang L; Luo M; Sun Q; Cai L; Lai Y; Xiao Z; Duan Z; Zheng S; Wu G; Hu R; Tsukamoto H; Lugea A; Liu Z; Pandol SJ; Han YP
    Front Physiol; 2016; 7():498. PubMed ID: 27895587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D Supplementation and Non-Alcoholic Fatty Liver Disease: Present and Future.
    Barchetta I; Cimini FA; Cavallo MG
    Nutrients; 2017 Sep; 9(9):. PubMed ID: 28906453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial Effects of Vitamin D Treatment in an Obese Mouse Model of Non-Alcoholic Steatohepatitis.
    Jahn D; Dorbath D; Kircher S; Nier A; Bergheim I; Lenaerts K; Hermanns HM; Geier A
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30609782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A narrative review on effects of vitamin D on main risk factors and severity of Non-Alcoholic Fatty Liver Disease.
    Sangouni AA; Ghavamzadeh S; Jamalzehi A
    Diabetes Metab Syndr; 2019; 13(3):2260-2265. PubMed ID: 31235166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From sugar to liver fat and public health: systems biology driven studies in understanding non-alcoholic fatty liver disease pathogenesis.
    Moore JB
    Proc Nutr Soc; 2019 Aug; 78(3):290-304. PubMed ID: 30924429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes.
    Cipponeri E; Vitturi N; Mariano V; Boscari F; Galasso S; Crepaldi C; Fadini GP; Vigili de Kreutzenberg S; Marescotti MC; Iori E; Cavallin F; Sartori L; Baritussio A; Avogaro A; Bruttomesso D
    J Endocrinol Invest; 2019 Sep; 42(9):1099-1107. PubMed ID: 30847862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of vitamin D supplementation on liver fibrogenic factors in non-alcoholic fatty liver patients with steatohepatitis: study protocol for a randomized clinical trial.
    Ebrahimpour-Koujan S; Sohrabpour AA; Foroughi F; Alvandi E; Esmaillzadeh A
    Trials; 2019 Mar; 20(1):153. PubMed ID: 30832722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D Deficiency Is Associated With Increased Risk of Non-alcoholic Steatohepatitis in Adults With Non-alcoholic Fatty Liver Disease: Possible Role for MAPK and NF-κB?
    Nelson JE; Roth CL; Wilson LA; Yates KP; Aouizerat B; Morgan-Stevenson V; Whalen E; Hoofnagle A; Mason M; Gersuk V; Yeh MM; Kowdley KV
    Am J Gastroenterol; 2016 Jun; 111(6):852-63. PubMed ID: 27002799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.
    Clemente MG; Mandato C; Poeta M; Vajro P
    World J Gastroenterol; 2016 Sep; 22(36):8078-93. PubMed ID: 27688650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone metabolism in non-alcoholic fatty liver disease: vitamin D status and bone mineral density.
    Eshraghian A
    Minerva Endocrinol; 2017 Jun; 42(2):164-172. PubMed ID: 27973461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D supplementation for nonalcoholic fatty liver disease in type 2 diabetes mellitus: A protocol for a systematic review and meta-analysis.
    Wang S; Cai B; Han X; Gao Y; Zhang X; Wang R; Zhang Y; Chen Q
    Medicine (Baltimore); 2020 May; 99(19):e20148. PubMed ID: 32384501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between vitamin D and non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: results from a meta-analysis.
    Wang X; Li W; Zhang Y; Yang Y; Qin G
    Int J Clin Exp Med; 2015; 8(10):17221-34. PubMed ID: 26770315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D and nonalcoholic fatty liver disease.
    Zhang Z; Thorne JL; Moore JB
    Curr Opin Clin Nutr Metab Care; 2019 Nov; 22(6):449-458. PubMed ID: 31589177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.